Literature DB >> 35777882

Computerised cognitive training tools and online nutritional group counselling for people with mild cognitive impairment: study protocol of a completely digital, randomised, controlled trial.

Petra Scheerbaum1, Stephanie Book2, Michael Jank2,3, Etienne Hanslian4, Melanie DellO'ro4, Julia Schneider4, Julia-Sophia Scheuermann2, Sophia Bösl2, Michael Jeitler4, Christian Kessler4, Elmar Graessel2.   

Abstract

INTRODUCTION: People with mild cognitive impairment (MCI) are at increased risk of decreasing cognitive functioning. Computerised cognitive training (CCT) and nutrition have been shown to improve the cognitive capacities of people with MCI. For each variable, we developed two kinds of interventions specialised for people with MCI (CCT: 'individualised' CCT; nutrition: a whole-food, plant-based diet). Additionally, there are two kinds of active control measures (CCT: 'basic' CCT; nutrition: a healthy diet following the current guidelines of the German Nutrition Society). The aim of this study is to investigate the effects of the two interventions on cognition in people with MCI in a 2×2 randomised controlled trial with German participants. METHODS AND ANALYSIS: Participants will be community-dwelling individuals with a psychometric diagnosis of MCI based on the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination. With N=200, effects with an effect size of f≥0.24 (comparable to Cohen's d≥0.48) can be detected. Screening, baseline, t6 and t12 testing will be conducted via a videoconferencing assessment, telephone, and online survey. Participants will be randomly allocated to one of four groups and will receive a combination of CCT and online nutritional counselling. The CCT can be carried out independently at home on a computer, laptop, or tablet. Nutrition counselling includes 12 online group sessions every fortnight for 1.5 hours. The treatment phase is 6 months with follow-ups after six and 12 months after baseline. ETHICS AND DISSEMINATION: All procedures were approved by the Friedrich-Alexander-Universität Erlangen-Nürnberg Ethics Committee (Ref. 21-318-1-B). Written informed consent will be obtained from all participants. Results will be published in peer-reviewed scientific journals, conference presentations. TRIAL REGISTRATION NUMBER: ISRCTN10560738. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Delirium & cognitive disorders; GERIATRIC MEDICINE; NUTRITION & DIETETICS; Old age psychiatry

Mesh:

Year:  2022        PMID: 35777882      PMCID: PMC9252202          DOI: 10.1136/bmjopen-2021-060473

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   3.006


  77 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Construct Validity of the Montreal Cognitive Assessment (MoCA).

Authors:  Sandra Freitas; Mário R Simões; João Marôco; Lara Alves; Isabel Santana
Journal:  J Int Neuropsychol Soc       Date:  2011-11-24       Impact factor: 2.892

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 4.  Efficacy of cognitive intervention programs in amnesic mild cognitive impairment: A systematic review.

Authors:  I Gómez-Soria; P Peralta-Marrupe; E Calatayud-Sanz; E Latorre
Journal:  Arch Gerontol Geriatr       Date:  2021-01-14       Impact factor: 3.250

Review 5.  Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

Authors:  Ingrid Arevalo-Rodriguez; Nadja Smailagic; Marta Roqué I Figuls; Agustín Ciapponi; Erick Sanchez-Perez; Antri Giannakou; Olga L Pedraza; Xavier Bonfill Cosp; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2015-03-05

6.  The Association between Mushroom Consumption and Mild Cognitive Impairment: A Community-Based Cross-Sectional Study in Singapore.

Authors:  Lei Feng; Irwin Kee-Mun Cheah; Maisie Mei-Xi Ng; Jialiang Li; Sue Mei Chan; Su Lin Lim; Rathi Mahendran; Ee-Heok Kua; Barry Halliwell
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease.

Authors:  Sandra Freitas; Mário Rodrigues Simões; Lara Alves; Isabel Santana
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jan-Mar       Impact factor: 2.703

Review 8.  Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis.

Authors:  Nicole T M Hill; Loren Mowszowski; Sharon L Naismith; Verity L Chadwick; Michael Valenzuela; Amit Lampit
Journal:  Am J Psychiatry       Date:  2016-11-14       Impact factor: 18.112

9.  Validity of teleneuropsychology for older adults in response to COVID-19: A systematic and critical review.

Authors:  David E Marra; Kristin M Hamlet; Russell M Bauer; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2020-06-10       Impact factor: 3.535

10.  Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials.

Authors:  Jin-Tai Yu; Wei Xu; Chen-Chen Tan; Sandrine Andrieu; John Suckling; Evangelos Evangelou; An Pan; Can Zhang; Jianping Jia; Lei Feng; Ee-Heok Kua; Yan-Jiang Wang; Hui-Fu Wang; Meng-Shan Tan; Jie-Qiong Li; Xiao-He Hou; Yu Wan; Lin Tan; Vincent Mok; Lan Tan; Qiang Dong; Jacques Touchon; Serge Gauthier; Paul S Aisen; Bruno Vellas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-07-20       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.